Viking Therapeutics Stock Performance
as on September 12, 2026 at 2:15 pm IST
Day's Low
Day's High
$31.70$33.05
0.88%
Downside
3.35%
Upside
52 Week's Low
52 Week's High
$22.96$43.1528.21%
Downside
34.93%
Upside
Viking Therapeutics share price movements today
- Previous Close
- $32.13
- Open
- $32.26
- Volume
- 2.0M
- Market Cap
- $3.9B
- Day's Low - High
- $31.70 - $33.05
- 52 Week Low - High
- $22.96 - $43.15
Viking Therapeutics Historical Returns
- 1 Month Return
- -5.05 %
- 3 Month Return
- + 17.84 %
- 1 Year Return
- + 26.4 %
- 3 Year Return
- + 105.79 %
- 5 Year Return
- + 395.45 %
Viking Therapeutics Stock Fundamentals & Key Indicators
Check Viking Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.9B
EPS (TTM)
-4.66
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.02
Industry PE ratio
-13.83
PEG Ratio
0.08636693786049053
EBITDA
-534.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-94.56%
Viking Therapeutics Stock Valuation
Track how Viking Therapeutics P/E has moved over time to understand its valuation trends.
Viking Therapeutics in the last 5 years
Lowest (-39.84x)
December 31, 2024
Industry (-13.83x)
December 31, 2025
Today (-11.03x)
December 31, 2025
Highest (-6.46x)
December 31, 2021
Today’s Price to Earnings Ratio: -11.03x
Viking Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Viking Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $3.9B | 395.45% | -7.02 | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $138.4B | 181.2% | 30.54 | 86.04% | NA | |
| BUY | $56.0B | -69.82% | -16.99 | -12.57% | NA | |
| BUY | $85.2B | 24.16% | 19.28 | 84.86% | 45.660000000000004% |
Stock Returns calculator for Viking Therapeutics Stock including INR - Dollar returns
The Viking Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Viking Therapeutics investment value today
Current value as on today
₹1,33,789
Returns
₹33,789
(+33.79%)
Returns from Viking Therapeutics Stock
₹23,618 (+23.62%)
Dollar Impact
₹10,171 (+10.17%)
Analyst Recommendation on Viking Therapeutics Stock
Based on 14 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 14 analysts, 100% of analysts recommend a 'BUY' rating for Viking Therapeutics. Average target price of $92.39
Viking Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Viking Therapeutics.
What analysts predicted
65.39%UPSIDE
Target Price
$92.39
Current Price
$31.98
Analyzed by
14 Analysts
Target
$92.39
Viking Therapeutics target price $92.39, a slight upside of 65.39% compared to current price of $31.98. According to 14 analysts rating.
Indian Investors' Interest in Viking Therapeutics Stock
Investment in Viking Therapeutics Shares on INDmoney has grown by 5.20% in the last 30 days, indicating increased investment activity.
Time period: to
Change:5.20% versus previous 30 day period
Search interest for Viking Therapeutics Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:3% versus previous 30 day period
Viking Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Viking Therapeutics Annual Profit & Loss
All numbers in Millions USD
Viking Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Viking Therapeutics Annual Cash Flow
All numbers in Millions USD
Viking Therapeutics News & Key Events
Today's Timeline - 08 July
Wed, 10:41 AM
-VKTX stock jumps 9% as analysts project a 120% upside; Piper Sandler reiterates Overweight rating.
Wed, 11:42 AM
-Viking Therapeutics initiates Phase 1 trial for VK3019, a new obesity drug, following FDA clearance.
Wed, 07:40 PM
-Viking Therapeutics advances VK2735 for obesity treatment, targeting Phase 3 development by Q4 2026.
Insights on Viking Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, VKTX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 483.5%
NEGATIVE IMPACTPrice Dip
In the last 7 days, VKTX stock has moved down by -8.3%
About Viking Therapeutics
| Organisation | Viking Therapeutics |
| Headquarters | 9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121 |
| Industry | Biotechnology |
| CEO | Dr. Brian Lian Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Viking Therapeutics
Name | Title |
|---|---|
Dr. Brian Lian Ph.D. | President, CEO & Director |
Mr. Gregory S. Zante CPA | Chief Financial Officer |
Mr. Michael Morneau | Vice President of Finance & Administration |
Dr. Geoffrey E. Barker Ph.D. | Chief Development Officer |
Ms. Katherine Mercier | Vice President of Quality & Compliance |
Mr. Kenneth J. Herman M.B.A. | Senior Vice President of Commercial, Marketing & Sales |
Mr. Neil Aubuchon B.A., M.B.A. | Chief Commercial Officer |
Dr. Nils U. Olsson Ph.D. | Senior Vice President of Technical Operations |
Dr. Hubert C. Chen M.D., M.P.H. | Chief Medical Officer |
FAQs
What is Viking Therapeutics share price today?
Viking Therapeutics share price today is $31.98 as on at the close of the market. Viking Therapeutics share today touched a day high of $33.05 and a low of $31.70.
What is the 52 week high and 52 week low for Viking Therapeutics share?
Viking Therapeutics share touched a 52 week high of $43.15 on and a 52 week low of $22.96 on . Viking Therapeutics stock price today i.e. is closed at $31.98,which is 25.89% down from its 52 week high and 39.29% up from its 52 week low.
What is Viking Therapeutics's market capitalisation today?
Viking Therapeutics market capitalisation is $0.00T as on .
How to invest in Viking Therapeutics Stock (VKTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Viking Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viking Therapeutics Shares that will get you 0.0469 shares as per Viking Therapeutics share price of $31.98 per share as on September 12, 2026 at 8:45 am IST.
What is the minimum amount required to buy Viking Therapeutics Stock (VKTX) from India?
Indian investors can start investing in Viking Therapeutics (VKTX) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Viking Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Viking Therapeutics share’s latest price of $31.98 as on September 12, 2026 at 8:45 am IST, you will get 0.3127 shares of Viking Therapeutics. Learn more about
fractional shares .
What are the returns that Viking Therapeutics has given to Indian investors in the last 5 years?
Viking Therapeutics stock has given 395.45% share price returns and 29.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?